Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial

Overview of attention for article published in BMC Psychiatry, August 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter: 5 X users

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 93 Mendeley

Summary X Wikipedia Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 2,145 followers.

@akuuttigeriatri @TeppoSyvarila @LahtinenMikko @NevalainenOlli @Kaeaentoepuoli @SinakinB @kailintunen @Liberaalipuolue @MattiMuukkonen Ja hoidettaisiin parhaalla mahdollisella tavalla. https://t.co/m8d5228UyR

10 Mar 2023

Reply Repost Favourite

Exciting study being done in DK looking at those with dual diagnosis.

28 Oct 2021

Reply Repost Favourite

Exiting new study exploring the effects of cannabidiol on psychosis 💊

28 Oct 2021

Reply Repost Favourite

New study led by Jesper Østrup Rasmussen and Lone Baandrup evaluates the efficacy of cannabidiol versus a first-choice second-generation antipsychotic (risperidone) in patients with early psychosis and comorbid cannabis use https://t.co/UTNG3ue24d

28 Oct 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.